Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.


Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Understanding and Empowering Patients

At Otsuka Europe, we’re committed to doing things differently. That means developing medicines and providing supportive care, that more closely meet your needs.

We want to better understand patient, family and caregiver experiences

If you are living with a diagnosis, caring for someone who is, or supporting others through a patient organisation, we want to learn from you.

Sharing your experiences helps shape patient care.

Why your experience matters to Otsuka

Your experiences can make a real difference. By sharing your story, you can help us improve healthcare in ways that truly matter to patients and their families. You can help create change by sharing:
  • What matters most to you
  • How your diagnosis impacts your quality of life
Your real-world insights help us advance:
  • Access to medicines
  • Medical guidelines and health policies
Together, we can empower people by supporting their:
  • Understanding of health information
  • Management of symptoms and side effects
Help Otsuka stay accountable and fulfill our commitment to patients.

Otsuka Pharmaceutical Europe Ltd. - 2026 Patient Organisation Sponsorships

  • EURORDIS (Rare Diseases Europe) - Otsuka Pharmaceutical Europe Ltd provided financial support through sponsorship to help EURORDIS continue their mission to support the rare disease patient voice. Financial support has contributed towards EURORDIS operational costs.
  • Acute Leukemia Advocates Network (ALAN) - Otsuka Pharmaceutical Europe Ltd provided financial support through sponsorship for EHA & ASH congress reports and infographics. Otsuka has had no influence or involvement in the creation of the materials.
  • HAE International (HAEi) - Otsuka Pharmaceutical Europe Ltd provided financial support through sponsorship for the HAEi Global Angioedema Leadership Conference. Financial support has contributed towards patient travel grants. Otsuka has had no influence or involvement in the delivery of the conference.
  • HAE International (HAEi) - Otsuka Pharmaceutical Europe Ltd provided financial support through sponsorship for HAEi 2026 Core activities. Financial support has contributed towards to strengthening HAEi’s essential technological platforms, educational services, and programs for member organisations and patients.
To find out more please visit Patient Organisations and the Public Transparency Information

Over the last 3 years*:

>675K

people treated with an Otsuka medicine in Europe, across multiple therapeutic areas1

27

European countries enrolling people in Otsuka clinical trials, generating national data to support medicines access1

60+

European Patient Organisations have been supported via Otsuka Sponsorships, Grants or Donations, helping them raise awareness and advocate on behalf of their communities1

* Years 2022, 2023, 2024
1. Data on file

Date of preparation: May 2026 | Reference: OPE-NPR-2600012 (v1.0)

Date of preparation: May 2026 | Reference OPE-NPR-2300022 (v6.0)

Copyright © 2020 - 2026 Otsuka Pharmaceutical Europe Ltd. All rights reserved.
Registered in England and Wales with company no. 03456326.
Registered office: 2 Windsor Dials, Arthur Road, Windsor, Berkshire, SL4 1RS

This website is intended for all audiences with an interest in Otsuka Pharmaceutical Europe Ltd.